drugset
drugset / Trial / NCT02894541

Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

NCT02894541 ↗

Phase 1 Completed 48 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519.

Timeline

Start
2016-08
Primary completion
2016-11
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ROCACETRAPIB Small molecule 100 mg —
Subject ROCACETRAPIB Small molecule 200 mg —

Indications

No indication recorded.